10-K Decoder · All companies

SAB Biotherapeutics, Inc.

SABS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$1.32M−100%
Operating income−$49.0M−$42.9M−14.1%
Net income$4.26M−$34.1M

Questions

What was SAB Biotherapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $1.32M a year earlier, per its 10-K filed Mar 2026.
Was SAB Biotherapeutics profitable in FY2025?
Yes: net income was $4.26M and operating income −$49.0M in FY2025.